Center for Scientific Review; Notice of Closed Meetings, 4935-4937 [2015-01612]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 19 / Thursday, January 29, 2015 / Notices
Dated: January 22, 2015.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2015–01685 Filed 1–28–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
Potential Commercial Applications
• Drug Development
• Toxicity Studies
• Drug Design
National Institutes of Health,
HHS.
ACTION:
Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 209 and 37 CFR part 404 to
achieve expeditious commercialization
of results of federally-funded research
and development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
U.S. patent applications listed below
may be obtained by writing to the
indicated licensing contact at the Office
of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301–
496–7057; fax: 301–402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
SUPPLEMENTARY INFORMATION:
Technology descriptions follow.
SUMMARY:
mstockstill on DSK4VPTVN1PROD with NOTICES
Miniature System for Manipulating
Small Animals in High-Throughput
Screening Small Molecules
Description of Technology: The
invention pertains to a miniaturized
plating and feeding system based on a
96-well microplate base and is intended
to reduce manipulation of organisms as
well as amounts of test drug/anesthetic,
thereby mitigating waste. The kit
comprises a feeder plate, transfer
adaptor and receiver plate. The feeder
plate is defined by, for example, a
plastic 96-well plate with rounded
wells. The rounded bottoms can
dispense to or permit access to the test
organism of liquid food or drug through
about 7 holes of approximately 350
microns in diameter. A top portion of
the well provides test organisms (e.g.,
drosophila, daphnia) with sufficient
VerDate Sep<11>2014
18:16 Jan 28, 2015
Jkt 235001
space to enjoy normal life-cycles
without confinement stress. The feeder
plate includes means for interfacing
with complementary components of the
transfer and receiver plates through
receiving holes and complementary
dowels or pins. A transfer adapter
allows the interconnection of the feeder
plate to the receiver plate. The transfer
plate can be configured to be square or
rounded for the transfer of organisms
from the feeder plate to the receiver
plate.
• A LRRK2 inhibitor would be a
unique form of anti-inflammatory
therapy that will complement or
compete with an array of cytokines in
primary treatment for lBD.
• A LRRK2 inhibitor would provide a
much needed alternate mode of therapy.
Small animals
High Throughput
Space efficiency
Resource economy
Development Stage
• Early stage
• Prototype
Inventors: Maria De Los Angeles Jaime
and Brian Oliver (NIDDK).
Intellectual Property: HHS Reference
No. E–034–2015/0—US Provisional
Application No. 62/080,181 filed
November 14, 2015.
Licensing Contact: Michael
Shmilovich, Esq.; 301–435–5019;
shmilovm@mail.nih.gov.
Collaborative Research Opportunity:
The National Institute of Diabetes and
Digestive and Kidney Diseases is
seeking statements of capability or
interest from parties interested in
collaborative research to further
develop, evaluate or commercialize
High-Throughput Small Animal
Manipulation for Drug Design. For
collaboration opportunities, please
contact Marguerite J. Miller at
millermarg@niddk.nih.gov.
LRKK2 Inhibitors: Novel Treatment for
Intestinal Bowel Disorders
Description of Technology: Use of
Leucine Rich Repeat Kinase 2 (LRRK2)
inhibitors for the treatment of Intestinal
Bowel Disorders (IBD) is disclosed. IBD
is a broad term that describes conditions
with chronic or recurring immune
response and inflammation of the
gastrointestinal tract. Crohn’s disease
and ulcerative colitis, two common
forms of idiopathic IBD, are chronic,
relapsing inflammatory disorders of the
gastrointestinal tract.
LRRK2 is a kinase encoded by a gene
that contains a non-coding
polymorphism (SNP). LRRK2 has been
associated with and is a risk factor for
inflammatory bowel disease. NIH
PO 00000
Frm 00083
Fmt 4703
inventors have shown that human cells
expressing this SNP have increased
levels of LRRK2 and, correspondingly,
mice with increased levels of LRRK2
exhibit more severe Dextran Sulfate
colitis. In various studies of the role of
LRRK2 in cell signaling, NIH inventors
have shown that increased levels of
LRRK2 lead to increased proinflammatory cytokine secretion. Also,
an inhibitor of LRRK2 is shown to
abrogate the pro-inflammatory activity
of LRRK2 both in vitro and in vivo.
Potential Commercial Applications:
Treatment for or prevention of Intestinal
Bowel Disorders.
Competitive Advantages
Competitive Advantages
•
•
•
•
4935
Sfmt 4703
Development Stage
• Early-stage
• In vitro data available
• In vivo data available (animal)
Inventors: Warren Strober, Ivan J.
Fuss, Tetsuya Takagawa, Atsushi Kitani
(all of NIAID).
Intellectual Property: HHS Reference
No. E–070–2014/0—US Provisional
Application No. 61/993,637 filed May
15, 2014.
Licensing Contact: Suryanarayana
Vepa, Ph.D., J.D.; 301–435–5020;
vepas@mail.nih.gov.
Dated: January 22, 2015.
Richard U. Rodriguez,
Acting Director, Office of Technology
Transfer, National Institutes of Health.
[FR Doc. 2015–01610 Filed 1–28–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
E:\FR\FM\29JAN1.SGM
29JAN1
4936
Federal Register / Vol. 80, No. 19 / Thursday, January 29, 2015 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Clinical and Integrative
Cardiovascular Sciences Study Section.
Date: February 19–20, 2015.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Yuanna Cheng, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138,
MSC 7814, Bethesda, MD 20892, (301)435–
1195, Chengy5@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Cancer Immunopathology and
Immunotherapy Study Section.
Date: February 23–24, 2015.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites DC Convention
Center, 900 10th St. NW., Washington, DC
20001.
Contact Person: Denise R Shaw, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804, Bethesda, MD 20892, 301–435–
0198, shawdeni@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel.
Date: February 24, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Bahiru Gametchu, DVM,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4204,
MSC 7812, Bethesda, MD 20892, 301–435–
1225, gametchb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–12–
186: Macroeconomic Aspects of Population
Aging.
Date: February 24, 2015.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Suzanne Ryan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 435–
1712, ryansj@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Acute Neural Injury and Epilepsy
Study Section.
Date: February 26–27, 2015.
VerDate Sep<11>2014
18:16 Jan 28, 2015
Jkt 235001
Time: 7:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Best Western Tuscan Inn, 425 North
Point Street, San Francisco, CA 94133.
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Fellowships:
Neurodevelopment, Synaptic Plasticity and
Neurodegeneration.
Date: February 26–27, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The St. Regis Washington DC, 923
16th Street NW., Washington, DC 20006.
Contact Person: Mary Schueler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214,
MSC 7846, Bethesda, MD 20892, 301–451–
0996, marygs@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group,
Integrative Physiology of Obesity and
Diabetes Study Section.
Date: February 26–27, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Reed A. Graves, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6166,
MSC 7892, Bethesda, MD 20892, (301) 402–
6297, gravesr@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group,
Musculoskeletal Rehabilitation Sciences
Study Section.
Date: February 26–27, 2015.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Admiral Fell Inn, 888 South
Broadway, Baltimore, MD 21231.
Contact Person: Maria Nurminskaya, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, Bethesda, MD 20892, (301) 435–1222,
nurminskayam@csr.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group,
Cancer Genetics Study Section.
Date: February 26–27, 2015.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Marriott at Metro
Center, 775 12th St. NW., Washington, DC
20005.
Contact Person: Michael L. Bloom, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187,
MSC 7804, Bethesda, MD 20892, 301–451–
0132, bloomm2@mail.nih.gov.
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group, Neurogenesis and Cell Fate
Study Section.
Date: February 26–27, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn San Francisco
Fisherman’s Wharf, 1300 Columbus Avenue,
San Francisco, CA 94133.
Contact Person: Joanne T. Fujii, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4184,
MSC 7850, Bethesda, MD 20892, (301) 435–
1178, fujiij@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group, Clinical Neuroscience and
Neurodegeneration Study Section.
Date: February 26–27, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Kabuki, 1625 Post Street, San
Francisco, CA 94115.
Contact Person: Samuel C. Edwards, Ph.D.,
Chief, Brain Disorders and Clinical
Neuroscience, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5210, MSC 7846, Bethesda, MD
20892, (301) 435–1246, edwardss@
csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Virology—B Study Section.
Date: February 26–27, 2015.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Kabuki, 1625 Post Street, San
Francisco, CA 94115.
Contact Person: John C. Pugh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1206,
MSC 7808, Bethesda, MD 20892, (301) 435–
2398, pughjohn@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Molecular
Genetics A Study Section.
Date: February 26–27, 2015.
Time: 8:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance M Street Hotel, 1143
New Hampshire Avenue NW.,Washington,
DC 20037.
Contact Person: Michael M. Sveda, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1114,
MSC 7890, Bethesda, MD 20892, 301–435–
3565, svedam@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\29JAN1.SGM
29JAN1
Federal Register / Vol. 80, No. 19 / Thursday, January 29, 2015 / Notices
Dated: January 23, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
Dated: January 23, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–01612 Filed 1–28–15; 8:45 am]
[FR Doc. 2015–01611 Filed 1–28–15; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
National Institutes of Health
[Docket No. FR–5630–N–06]
National Institute on Aging; Notice of
Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Alzheimer’s
Disease Drug Development.
Date: February 24, 2015.
Time: 12:30 p.m. to 3:30 p.m..
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 2C212, 7201 Wisconsin
Avenue, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, National
Institute on Aging, Gateway Building 2C212,
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–496–9666, parsadaniana@
nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, 2015 Beeson
Review.
Date: February 27, 2015.
Time: 8:00 a.m. to 4:00 p.m..
Agenda: To review and evaluate grant
applications.
Place: Doubletree Bethesda,8210
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, National
Institute on Aging, Gateway Building 2C212,
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–496–9666, parsadaniana@
nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
VerDate Sep<11>2014
18:16 Jan 28, 2015
Jkt 235001
Rental Assistance Demonstration
(RAD)—Updated Application Review
and Commitments To Enter Into
Housing Assistance Payment
Contracts (CHAPs) Issuance Process
for First Component RAD Transactions
Office of the Assistant
Secretary for Public and Indian
Housing, and Office of the Assistant
Secretary for Housing—Federal Housing
Commissioner, HUD.
ACTION: Notice.
AGENCY:
As a result of increased
authority granted to HUD in the
Consolidated and Further Continuing
Appropriations Act, 2015 (Pub. L. 113–
235, approved December 16, 2014) (FY
2015 Appropriations Act) to convert
public housing and moderate
rehabilitation (Mod Rehab) program
assistance under the first component of
RAD for a total of 185,000 units, HUD
will review all applications on the
waitlist and begin issuing CHAPs in
accordance with this notice to maximize
the effectiveness of the proposed
conversion of assistance. HUD
welcomes comment on the update of the
review process provided in this notice.
DATES: Comment Due Date: March 2,
2015.
ADDRESSES: Interested persons are
invited to submit comments regarding
this notice. Communications must refer
to the above docket number and title.
There are two methods for submitting
public comments. All submissions must
refer to the above docket number and
title.
1. Submission of Comments by Mail.
Comments may be submitted by mail to
the Regulations Division, Office of
General Counsel, Department of
Housing and Urban Development, 451
7th Street SW., Room 10276,
Washington, DC 20410–0500.
2. Electronic Submission of
Comments. Interested persons may
submit comments electronically through
the Federal eRulemaking Portal at
www.regulations.gov. HUD strongly
encourages commenters to submit
comments electronically. Electronic
submission of comments allows the
SUMMARY:
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
4937
commenter maximum time to prepare
and submit comments, ensures timely
receipt by HUD, and enables HUD to
make them immediately available to the
public. Comments submitted
electronically through the
www.regulations.gov Web site can be
viewed by other commenters and
interested members of the public.
Commenters should follow the
instructions provided on that site to
submit comments electronically.
Note: To receive consideration as public
comments, comments must be submitted
through one of the two methods specified
above. Again, all submissions must refer to
the docket number and title of the notice.
No Facsimile Comments. Facsimile
(FAX) comments are not acceptable.
Public Inspection of Public
Comments. All properly submitted
comments and communications
submitted to HUD will be available for
public inspection and copying between
8 a.m. and 5 p.m. Eastern Time
weekdays at the above address. Due to
security measures at the HUD
Headquarters building, an advance
appointment to review the public
comments must be scheduled by calling
the Regulations Division at 202–708–
3055 (this is not a toll-free number).
Individuals with speech or hearing
impairments may access this number
through TTY by calling the Federal
Relay Service at 800–877–8339. Copies
of all comments submitted are available
for inspection and downloading at
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Janet Golrick, Acting Director of the
Office of Recapitalization, Office of
Housing, Department of Housing and
Urban Development, 451 7th Street SW.,
Washington, DC 20410–7000; telephone
number 202–708–0001 (this is not a tollfree number). Hearing- and speechimpaired persons may access these
numbers through TTY by calling the
Federal Relay Service at 800–877–8339
(this is a toll-free number).
I. Background and Explanation
The Consolidated and Further
Continuing Appropriations Act, 2012
(Pub. L. 112–55, approved November
18, 2011) limited the conversion of
60,000 public housing and Mod Rehab
units under the first component of
RAD.1 The applications for RAD
conversions under the first component
exceeded this unit cap and an applicant
waiting list started in approximately
1 The first component of RAD allows projects
funded under the public housing and Mod Rehab
programs to convert to long-term Section 8 rental
assistance contracts with their current subsidy
levels under the RAD demonstration program.
E:\FR\FM\29JAN1.SGM
29JAN1
]]>Agencies
[Federal Register Volume 80, Number 19 (Thursday, January 29, 2015)]
[Notices]
[Pages 4935-4937]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01612]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning
[[Page 4936]]
individuals associated with the grant applications, the disclosure of
which would constitute a clearly unwarranted invasion of personal
privacy.
Name of Committee: Cardiovascular and Respiratory Sciences
Integrated Review Group; Clinical and Integrative Cardiovascular
Sciences Study Section.
Date: February 19-20, 2015.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Yuanna Cheng, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138, MSC 7814, Bethesda, MD
20892, (301)435-1195, Chengy5@csr.nih.gov.
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Cancer Immunopathology and Immunotherapy Study
Section.
Date: February 23-24, 2015.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites DC Convention Center, 900 10th St. NW.,
Washington, DC 20001.
Contact Person: Denise R Shaw, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6158, MSC 7804, Bethesda, MD 20892, 301-435-
0198, shawdeni@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel.
Date: February 24, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Bahiru Gametchu, DVM, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4204, MSC 7812, Bethesda, MD
20892, 301-435-1225, gametchb@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-12-186: Macroeconomic Aspects of Population Aging.
Date: February 24, 2015.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Suzanne Ryan, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD 20892, (301) 435-
1712, ryansj@csr.nih.gov.
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Acute Neural Injury and Epilepsy Study
Section.
Date: February 26-27, 2015.
Time: 7:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Best Western Tuscan Inn, 425 North Point Street, San
Francisco, CA 94133.
Contact Person: Seetha Bhagavan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD
20892, (301) 237-9838, bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Fellowships: Neurodevelopment, Synaptic Plasticity and
Neurodegeneration.
Date: February 26-27, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The St. Regis Washington DC, 923 16th Street NW.,
Washington, DC 20006.
Contact Person: Mary Schueler, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5214, MSC 7846, Bethesda, MD 20892, 301-451-
0996, marygs@csr.nih.gov.
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences Integrated Review Group, Integrative
Physiology of Obesity and Diabetes Study Section.
Date: February 26-27, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Reed A. Graves, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6166, MSC 7892, Bethesda, MD
20892, (301) 402-6297, gravesr@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral and Skin Sciences
Integrated Review Group, Musculoskeletal Rehabilitation Sciences
Study Section.
Date: February 26-27, 2015.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Admiral Fell Inn, 888 South Broadway, Baltimore, MD
21231.
Contact Person: Maria Nurminskaya, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, Bethesda, MD 20892, (301) 435-1222,
nurminskayam@csr.nih.gov.
Name of Committee: Oncology 1--Basic Translational Integrated
Review Group, Cancer Genetics Study Section.
Date: February 26-27, 2015.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Marriott at Metro Center, 775 12th St. NW.,
Washington, DC 20005.
Contact Person: Michael L. Bloom, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187, MSC 7804, Bethesda, MD
20892, 301-451-0132, bloomm2@mail.nih.gov.
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group, Neurogenesis and Cell Fate
Study Section.
Date: February 26-27, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Holiday Inn San Francisco Fisherman's Wharf, 1300
Columbus Avenue, San Francisco, CA 94133.
Contact Person: Joanne T. Fujii, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4184, MSC 7850, Bethesda, MD
20892, (301) 435-1178, fujiij@csr.nih.gov.
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group, Clinical Neuroscience and Neurodegeneration
Study Section.
Date: February 26-27, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Kabuki, 1625 Post Street, San Francisco, CA 94115.
Contact Person: Samuel C. Edwards, Ph.D., Chief, Brain Disorders
and Clinical Neuroscience, Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive, Room 5210, MSC 7846,
Bethesda, MD 20892, (301) 435-1246, edwardss@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group; Virology--B Study Section.
Date: February 26-27, 2015.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Kabuki, 1625 Post Street, San Francisco, CA 94115.
Contact Person: John C. Pugh, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435-
2398, pughjohn@csr.nih.gov.
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Molecular Genetics A Study Section.
Date: February 26-27, 2015.
Time: 8:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance M Street Hotel, 1143 New Hampshire Avenue
NW.,Washington, DC 20037.
Contact Person: Michael M. Sveda, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1114, MSC 7890, Bethesda, MD
20892, 301-435-3565, svedam@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
[[Page 4937]]
Dated: January 23, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-01612 Filed 1-28-15; 8:45 am]
BILLING CODE 4140-01-P
